Regular ArticleMapping Epitope Structure and Activity: From One-Dimensional Prediction to Four-Dimensional Description of Antigenic Specificity
Abstract
Our knowledge of antigenic specificity has greatly increased in recent years mainly through X-ray crystallographic studies of proteins and peptides complexed with monoclonal antibodies. However, our ability to predict the location of antigenic sites in proteins remains limited partly because prediction algorithms reduce the complexity of epitopes to one-dimensional, linear peptide models. Epitopes and paratopes are relational entities definable by their mutual complementarity and adaptation potential as well as by their activity. A complete account of antigenic specificity demands the integration of both structural and binding activity data that can be achieved only through a spatiotemporal four-dimensional analysis. Failure to include the fourth dimension, i.e., time, in the analysis of antigen–antibody complementarity amounts to considering proteins as rigid bodies and ignores the mutual adaptation that occurs when the two partners interact. Reducing four-dimensional protein systems to three-dimensional or two-dimensional representations inevitably distorts our perception of the dynamic nature of epitopes.
References (0)
Cited by (204)
Recent advances in surface plasmon resonance as a powerful approach for studying Leishmania spp. and Trypanosoma cruzi parasites
2023, Talanta OpenLeishmaniases and Chagas disease pose significant health challenges, particularly in tropical regions among impoverished communities. These conditions prevail in areas characterized by limited resources and have necessitated the continuous development of various techniques for the detection and identification of causative parasites of both diseases since the early 20th century. The demand for rapid, sensitive, and practical diagnostic tools, especially for point-of-care applications, has led to the exploration of biosensors as a promising approach to addressing this critical need. This review discusses Surface Plasmon Resonance (SPR) technology, as a robust and sensitive tool to assess proteins from Leishmania spp. and Trypanosoma cruzi, as well as their interplay within host organisms. Closely related methodologies, encompassing both SPR and SPR Imaging (SPRi), underscoring their contributions to unraveling the intricate dynamics inherent to the host-parasite interface are addressed. Furthermore, practical aspects of SPR experimentation, including the utilization of sensor chips featuring self-assembled monolayer-based gold surfaces and non-cross-linked carboxymethylated dextran, are shown as an update on our understanding of SPR assays in the context of molecular recognitions within the parasite-host interaction framework. Recent discoveries encompassing parasite biology, interactions with compounds relevant to chemotherapy, and the intricate interplay of cellular, humoral, and innate immune responses, all facilitated by SPR technology are discussed.
Immunoinformatics-based multi-epitope vaccine design for the re-emerging monkeypox virus
2023, International ImmunopharmacologyOn May 7, 2022, WHO reported a new monkeypox case. By May 2023 over 80,000 cases had been reported worldwide outside previously endemic nations. (This primarily affected the men who have sex with men (MSM) community in rich nations). The present research aims to develop a multi-epitope vaccine for the monkeypox virus (MPXV) using structural and cell surface proteins.
The first part of the research involved retrieving protein sequences. The Immune Epitope Database (IEDB) was then used to analyze the B and T lymphocyte epitopes. After analyzing the sensitizing properties, toxicity, antigenicity, and molecular binding, appropriate linkers were utilized to connect selected epitopes to adjuvants, and the structure of the vaccine was formulated. Algorithms from the field of immunoinformatics predicted the secondary and tertiary structures of vaccines. The physical, chemical, and structural properties were refined and validated to achieve maximum stability. Molecular docking and molecular dynamic simulations were subsequently employed to assess the vaccine’s efficacy. Afterward, the ability of the vaccine to interact with toll-like receptors 3 and 4 (TLR3 and TLR4) was evaluated. Finally, the optimized sequence was then introduced into the Escherichia coli (E. coli) PET30A + vector.
An immunoinformatics evaluation suggested that such a vaccine might be safe revealed that this vaccine is safe, hydrophilic, temperature- and condition-stable, and can stimulate innate immunity by binding to TLR3 and TLR4.
Our findings suggest that the first step in MPXV pathogenesis is structural and cell surface epitopes. In this study, the most effective and promising epitopes were selected and designed through precision servers. Furthermore, through the utilization of multi-epitope structures and a combination of two established adjuvants, this research has the potential to be a landmark in developing an antiviral vaccine against MPXV. However, additional in vitro and in vivo tests are required to confirm these results.
Epitopes, paratopes, and other topes 30 years on: Understanding what we are talking about
2023, Human ImmunologyThe question of which protein antigens, such as HLA class I or class II molecules, will bind, and how well, to a given antibody is often assumed to depend exclusively on the details of protein surface structure. These structures are usually based on static models resulting from X-ray crystallography. While these notions are useful, the ultimate causal factors determining how well a given antigen binds a given antibody are based in thermodynamics and can include atomic mobility and the time-varying conformations of proteins. In this article, fundamental biophysical principles of antibody-antigen interaction are discussed, concepts critical for a deeper understanding of the pertinent molecular phenomena are highlighted, and common misunderstandings are identified and debunked.
A multi-epitope based vaccine against the surface proteins expressed in cyst and trophozoite stages of parasite Entamoeba histolytica
2023, Journal of Immunological MethodsEntamoeba histolytica, an anaerobic parasite, infects humans and other primates and causes fatal diseases, such as amebiasis, amebic liver abscesses, and many others. Thousands of people are infected and dying due to the need for a proper protective cure, especially in poor sanitizing regions, such as Latin America, Asia, and Africa. Around 10% of the world population is infected by E. histolytica every year. Consequently, novel preventive approaches are required to eliminate the threats of the parasite. A designed vaccine targeting the exposed proteins that are common between cyst and trophozoite stages of the parasite's life cycle would be an effective way to repress the impact of the parasite. Therefore, an in silico bioinformatics approach was performed to design an effective vaccine targeting surface proteins common between both stages of the parasite's life cycle using B-cell and T-cell epitopes. The epitopes derived from the conserved portions of the proteins and their corresponding isomers specific to the parasite suggested that the vaccine could benefit cross-protection. Furthermore, the three-dimensional structure of the designed vaccine was modelled, refined, and validated using multiple bioinformatics tools. The physiological properties and solubility were also predicted using different algorithmic tools and found to be highly soluble in nature. The vaccine was found interactcted with TLR immune receptors, and the stability was observed via dynamics simulation. Codon optimization and cloning were performed for expression analysis. Immune simulation prediction anticipated significant immune responses with a high IgG and IgM antibodies expression, Th and Tc cells population, B-cell population, memory cells, INF-γ, and IL-2 cytokines. Therefore, the constructed multi-epitope putative vaccine can effectively neutralize the parasite's harmful effects.
Identification of a linear B-cell epitope on the African swine fever virus CD2v protein
2023, International Journal of Biological MacromoleculesAfrican swine fever virus (ASFV) poses a serious threat to domestic pigs and wild boars, which is responsible for substantial production and economic losses. A dominant ASFV specific linear B cell epitope that reacted with the convalescent serum was explored and identified with the help of immune informatics techniques. It is essential in understanding the host immunity and in developing diagnostic technical guidelines and vaccine design. The confirmation of dominant epitopes with a positive serological matrix is feasible. To improve the immunogenicity of the epitope, we designed the dominant epitope of CD2v in the form of 2 branch Multiple-Antigen peptide (MAPs-2), CD2v-MAPs-2. Notably, CD2v peptide can be taken up by dendritic cells (DCs) to activate T lymphocytes and induce highly effective valence antibodies in BALB/c mice. The specific CD8+ T cell response were observed. The dominant epitope peptide identified in this study was able to effectively activate humoral and cellular immunity in mice model.
Brown spider venom phospholipases D: From molecular biology and structural analyses to potential vaccine and serum therapy applications
2023, Phospholipases in Physiology and Pathology: Volumes 1-7In this chapter, we initially elaborate on the identification and characterization of brown spider venom phospholipases D (BSVPLDs) based on “omics” approaches, with an emphasis on transcriptomic and proteomic analyses. Subsequently, we describe the production of recombinant BSVPLDs and the main challenges associated with the purification of these proteins directly from crude venoms. After that, the biophysical and structural aspects are described. We conclude by describing how recombinant BSVPLDs have been engineered to be used in therapeutic applications, such as in vaccine development, as a new generation serum, and as a putative model for the development of drugs.